Combinational chelation therapy abrogates lead-induced neurodegeneration in rats
Authors:
- Geetu SaxenaGSGeetu Saxena
- Ashish MehtaAMAshish Mehta
- Swaran J.S. FloraSwaran J.S. Flora
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 240 (2) , 255-264
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Response of lead-induced oxidative stress and alterations in biogenic amines in different rat brain regions to combined administration of DMSA and MiADMSAChemico-Biological Interactions, 2007
- Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned ratsJournal of Pharmacy and Pharmacology, 2006
- Cholinergic-induced production of reactive oxygen species in human neuroblastoma cellsLife Sciences, 1997
- Antioxidant and Prooxidant Properties of Captopril and EnalaprilFree Radical Biology and Medicine, 1997
- Combined Therapeutic Potential of meso-2,3-Dimercaptosuccinic Acid and Calcium Disodium Edetate on the Mobilization and Distribution of Lead in Experimental Lead Intoxication in RatsFundamental and Applied Toxicology, 1995
- Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen speciesChemico-Biological Interactions, 1991
- The Long-Term Effects of Exposure to Low Doses of Lead in ChildhoodNew England Journal of Medicine, 1990
- Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitorBiochemical and Biophysical Research Communications, 1989
- Converting-Enzyme Inhibitors in the Treatment of HypertensionNew England Journal of Medicine, 1988
- Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetesBMJ, 1988